PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportszollinger-ellison syndrome
MeSH D015043 - zollinger-ellison syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009384:Paraneoplastic endocrine syndromes
0 Companies
0 Drugs
Success rate
D013272:Stomach diseases
$
Success rate
D005770:Gastrointestinal neoplasms
$
Success rate
D010437:Peptic ulcer
D007410:Intestinal diseases
0 Companies
0 Drugs
Success rate
D015043: 
Zollinger-ellison syndrome
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareEsomeprazole Esomeprazole  2015-09-25   
Ajanta PharmaLansoprazole Lansoprazole  2016-10-14   
Naproxen, Esomeprazole strontium Naproxen Esomeprazole Magnesium  2022-10-06   
Omeprazole Omeprazole Bicarbonate  2016-07-15   
Pantoprazole Pantoprazole  2023-02-09   
Alkem LaboratoriesEsomeprazole strontium Esomeprazole Magnesium  2017-10-20   
Lansoprazole Lansoprazole  2019-01-18   
AllerganNaproxen, Esomeprazole strontium Naproxen Esomeprazole Magnesium  2022-08-24   
Omeprazole Omeprazole  2008-05-30   
Pantoprazole Pantoprazole  2011-02-07   
Amneal PharmaceuticalsEsomeprazole strontium Esomeprazole Magnesium  2019-04-10   
Pantoprazole Pantoprazole  2016-01-26   
ANDA RepositoryEsomeprazole strontium Esomeprazole Magnesium  2023-03-15   
Omeprazole Omeprazole Bicarbonate  2020-04-30   
ANI PharmaceuticalsLansoprazole Lansoprazole  2010-10-15   
Amoxicillin, Lansoprazole, Clarithromycin Lansoprazole, Amoxicillin Clarithromycin  2013-08-30   
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/2
Phase 2
0%
0/5
Phase 3
100%
12/12
Approved: 10Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use